Cardiac mortality · patients with restenosis after percutaneous coronary intervention in coronary heart disease
1 finding from 1 review
Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) (high certainty).
1 finding from 1 review
Restenosis Coronary angiography · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower restenosis Coronary angiography compared with conventional western medicine (CWM) (high certainty).
1 finding from 1 review
Recurrence angina pectoris Treadmill exercise test · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) probably leads to lower recurrence angina pectoris Treadmill exercise test compared with conventional western medicine (CWM) (moderate certainty).
1 finding from 1 review
Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause death: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with restenosis after percutaneous coronary intervention in coronary heart disease
1 finding from 1 review
Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) plus placebo (high certainty).
1 finding from 1 review
All‐cause mortality maximum · patients with coronary heart disease
Antibiotics showed no clear difference in all‐cause mortality at maximum compared with placebo or no intervention (high certainty).
1 finding from 1 review
Quality of life at 24±6 months · patients with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · patients with coronary heart disease
Antibiotics leads to higher cardiovascular mortality at 24±6 months compared with placebo or no intervention (high certainty).
2 findings from 1 review
Myocardial infarction · patients with coronary heart disease
Antibiotics showed no clear difference in myocardial infarction at 24±6 months compared with placebo or no intervention (moderate certainty).
2 findings from 1 review
Stroke · patients with coronary heart disease
Antibiotics showed no clear difference in stroke at 24±6 months compared with placebo or no intervention (high certainty).
2 findings from 1 review
Sudden cardiac death · patients with coronary heart disease
Antibiotics probably leads to higher sudden cardiac death at 24±6 months compared with placebo or no intervention (moderate certainty).
2 findings from 1 review
Serious adverse events maximum · patients with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life at maximum · patients with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at 24±6 months · patients with coronary heart disease
Antibiotics leads to higher all‐cause mortality at 24±6 months compared with placebo or no intervention (high certainty).
1 finding from 1 review
Serious adverse event at 24±6 months · patients with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality ( · adult patients with an implantable cardioverter defibrillator
Exercise showed no clear difference in all‐cause mortality ( compared with no exercise at the end of the intervention (low certainty).
1 finding from 1 review
Serious adverse events ( · adult patients with an implantable cardioverter defibrillator
Exercise showed no clear difference in serious adverse events ( compared with no exercise at the end of the intervention (low certainty).
1 finding from 1 review